Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

Hedge Fund - Wynnefield Capital

Nelson Obus And Joshua Landes Bio, Returns, AUM, Net Worth

Nelson Obus‘ Wynnefield Capital was founded in 1992 by Nelson Obus and Joshua Landes, who continue to act as the fund’s President and Executive Vice President/Treasurer/Secretary respectively. The small, employee-owned hedge fund caters to pooled investment vehicles and profit sharing plans.

The fund’s regulatory assets under management stood at $372 million as of July 6, 2017 with more than 75% of that amount being courtesy of pooled investment vehicles. Through the end of 2015 its small-cap value fund had delivered an annualized rate of return of 13.5% net of fees.

Wynnefield Capital primarily seeks out U.S-based small-cap stocks to invest in, stocks which it believes has or will have company- or industry-specific catalysts to drive growth. Among the potential factors and catalysts that the fund looks for in an investment are changes in government regulations which could have a positive impact on a company or industry, companies which have minimal debt or debt that is rapidly being paid down, and companies which are shareholder-friendly, especially those where the management team’s compensation is tied to shareholder value.

Wynnefield Capital is also an active manager, attempting to work together with the management teams of the companies in which it invests in an effort to help build on those catalysts and bring them to greater market attention, though the fund does not seek board representation in most cases. The fund has a long-term investment horizon for its core positions, which it holds for six-to-eight years on average.

Nelson Obus spent 12 years and millions of dollars battling insider trading charges which he was ultimately found innocent of by a jury in 2014. You can read about the details of Nelson Obus' insider trading ordeal here.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...... (read more)

After all, activist hedge funds get most of their earnings from investing in companies and pushing them to provide more shareholder value. These funds and their managers can start off with a statement...... (read more)

Nelson Obus' Wynnefield Capital recently filed an amended 13D filing with the US Securities and Exchange Commission, in which reports further lowering its stake in Omega Protein Corp (NYSE:OME) to 1....... (read more)

Is Omega Protein Corporation (NYSE:OME) a good stock to buy after its $5 plunge three weeks ago? We aren't too familiar with the stock but Nelson Obus' Wynnefield Capital which generally invests in small...... (read more)